Home » Authors » Nuala Moran

Nuala Moran

Articles

ARTICLES

YM BioSciences Plans Floats On AIM, TSE To Raise Up To C$40M

April 24, 2002

Molecular Skincare Spun Out To Develop Skin Disease Treatments

April 24, 2002

Xenova Enters Potential $63M Deal With Genentech For OX40

April 24, 2002

LONDON - Xenova Group plc signed a deal worth up to US$63 million plus royalties with Genentech Inc. for rights to Xenova’s preclinical OX40 program in immune inflammatory diseases. (BioWorld International)

Genentech, Xenova In Potential $63M Deal For OX40 Program

April 24, 2002

Genentech, Xenova In Potential $63M Deal For OX40 Program

April 24, 2002

Molecular Skincare Spun Out To Develop Skin Disease Treatments

April 24, 2002

Xenova Enters Potential $63M Deal With Genentech For OX40

April 24, 2002

LONDON - Xenova Group plc signed a deal worth up to US$63 million plus royalties with Genentech Inc. for rights to Xenova’s preclinical OX40 program in immune inflammatory diseases. (BioWorld International)

YM BioSciences Plans Floats On AIM, TSE To Raise Up To C$40M

April 24, 2002

Abbott Seeks Approvals For CAT’s Monoclonal Antibody

April 17, 2002

Paradigm, Genmab Collaborate In Therapeutic Antibodies Deal

April 17, 2002

View All Articles by Nuala Moran

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 25, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 25, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
In muscular dystrophies, gene therapies race the clock
BioWorld
Since the isolation of the gene that causes Duchenne muscular dystrophy (DMD), scientists have progressed in understanding the mechanisms that lead to muscular...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.